SMTL ID : 7olx.1

MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

monomer

Ligands

1 x VK5: ~{N}-[[3-[4-[(dimethylamino)methyl]phenyl]imidazo[1,2-a]pyridin-6-yl]methyl]-~{N}-methyl-5-[3-methyl-5-(1,3,5-trimethylpyrazol-4-yl)pyridin-2-yl]-1,3,4-oxadiazol-2-amine(Non-covalent)

VK5.1: 20 residues within 4Å: Chain A: L.27, V.35, A.51, K.53, M.55, F.68, E.71, A.72, M.75, I.84, L.86, V.103, L.105, P.106, F.107, M.108, M.164, A.174, D.175, F.176 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.27, A:V.35, A:A.51, A:A.72, A:I.84, A:I.84, A:L.86, A:V.103, A:L.105, A:F.176 Hydrogen bonds: A:K.53, A:M.108, A:D.175, A:D.175

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 4 residues within 4Å: Chain A: Y.235, P.236, L.253, K.254 Ligand excluded by PLIP CL.3: 2 residues within 4Å: Chain A: R.121, M.232 Ligand excluded by PLIP CL.4: 5 residues within 4Å: Chain A: I.84, R.85, P.106, M.108, R.166 Ligand excluded by PLIP CL.5: 2 residues within 4Å: Chain A: F.107, D.167 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McCoull, W. et al., Optimization of an Imidazo[1,2- a ]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy. J.Med.Chem. (2021)

Release Date

2021-09-15

Peptides

Tyrosine-protein kinase Mer: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase Mer

Related Entries With Identical Sequence